Medical device recalls Moderate risk

Medtronic Neuromodulation recalls A71200 Vanta" Clinician Programmer Application (CP App) version 2.0.2465 and 2.0.2683, Product number A71200. Software…

Recall date
December 3, 2025
Source
U.S. Food & Drug Administration (FDA) — enforcement report
Recall number
Z-1043-2026
FDA classification
Class II
Brand / firm
Medtronic Neuromodulation
Sold / distributed
Worldwide - US Nationwide distribution.

Why it was recalled

Complaints received that Vanta A71200 CP App does not function as intended during use. There is a potential for prolonged or postponed surgical procedure.

Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What was recalled

A71200 Vanta" Clinician Programmer Application (CP App) version 2.0.2465 and 2.0.2683, Product number A71200. Software is deployed and operated on Samsung tablets (CFN CT900).

Get recall alerts

Free email alert whenever Medtronic Neuromodulation has a new recall — straight from official government data. Unsubscribe anytime.

More recalls from: Medtronic Neuromodulation